Table 1.
Clinical characteristics of critically ill patients with COVID-19.
| CHARACTERISTIC | PATIENTS n = 83 |
|---|---|
| Gender (male) | 66 (79.5%) |
| Age (mean ± SD) | 61.2 ± 10.4 |
| APACHE II score (mean ± SD) | 18.8 ± 7.2 |
| SAPS II (mean ± SD) | 44.0 ± 14.8 |
| SOFA score at admission (mean ± SD) | 7.7 ± 2.8 |
| Mechanical ventilation | 78 (93.9%) |
| Vassopressors | 59 (71.0%) |
| Acute Renal Failure* | 4 (4.8%) |
| Central nervous system failure* | 3 (3.6%) |
| Liver failure* | 2 (2.4%) |
| ICU LOS (mean ± SD) | 19.7 ± 16.4 |
| Treatment | |
| Hydroxychoroquine sulfate | 76(91.5%) |
| Lopinavir,Ritonavir | 71(85.5%) |
| Remdesivir | 14(16.8%) |
| No antiviral treatment | 5(6.0%) |
| Tocilizumab | 50(60.2%) |
| Corticosteroids | 67(80.7%) |
Abbreviations: APACHE: Acute Physiology And Chronic Health Evaluation; SAPS: Sepsis-related Simplified Acute Physiology Score; SOFA: Organ Failure Assessment LOS = Length Of Stay.
⁎
Failure = 3 or 4 points in SOFA Score.